KMDANasdaqPharmaceutical PreparationsFiscal year ends December 31

KAMADA LTD

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 11, 2026

$7.61−0.15 (-1.93%)

Close on Oct 19, 2026

Market cap: –
P/E (TTM): 21.7
Dividend yield: –

KAMADA LTD income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31
Revenue	180	161	143	129	104	133	127	114	103	77	70
Cost of Revenue	104	91	87	83	73	86	77	73	71	56	55
Gross Profit	76	70	55	47	30	48	50	41	32	21	15
Research & Development	13	15	14	13	11	14	13	9.75	12	16	17
Selling, General & Admin	–	–	–	1.81	0.27	15	14	12	–	–	–
Selling & Marketing	18	18	16	15	6.28	4.52	4.37	3.63	4.40	3.24	3.65
General & Administrative	–	–	–	–	13	10	9.19	8.53	–	–	–
Operating Expenses	–	–	–	–	–	0.07	0.01	–	–	–	–
Operating Income	26	20	10	4.53	-0.70	19	23	19	7.44	-5.48	-11
Interest Expense	0.86	0.66	1.30	0.91	0.28	0.27	0.29	0.17	0.08	0.13	0.93
Interest & Investment Income	1.92	2.12	0.59	0.09	0.30	1.03	1.15	0.83	0.50	0.47	0.46
Pretax Income	23	13	8.43	-2.26	-1.89	19	23	20	7.17	-5.01	-11
Income Tax Expense	3.27	-1.13	0.15	0.06	0.35	1.43	0.73	-1.96	0.27	1.72	–
Income from Continuing Operations	–	–	–	-2.32	-2.23	–	–	–	–	–	–
Net Income incl. Noncontrolling Interests	20	14	8.28	-2.32	-2.23	17	22	22	6.90	-6.73	-11
Net Income	–	14	8.28	-2.32	–	–	–	–	–	–	–
EPS (Basic)(per share)	0.35	0.25	0.17	-0.05	-0.05	0.39	0.55	0.55	0.18	-0.18	-0.31
EPS (Diluted)(per share)	0.35	0.25	0.15	-0.05	-0.05	0.38	0.55	0.55	0.18	-0.18	-0.31
Shares Outstanding (Basic, Weighted)(shares)	58	57	49	45	45	44	40	40	38	36	36
Shares Outstanding (Diluted, Weighted)(shares)	58	58	54	45	45	45	41	40	38	36	36
EBITDA	41	34	23	17	4.91	24	27	23	11	-1.98	-8.20

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 40.8%
Operating margin: 14.5%
Net margin: –
Return on equity, FY2025: –

Financial strength

Current ratio: 4.06
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 60.0%

Valuation

P/E ratio: 21.7
Price to sales: –
Price to book: –
Dividend yield: –